Charming Medical Limited Class A Ordinary Shares (MCTA) Stock

About Charming Medical Limited Class A Ordinary Shares

Operating through its subsidiaries and under the Beauty Lab brand in Hong Kong, Charming Medical Limited delivers a comprehensive suite of beauty, wellness, and postpartum services. These services encompass womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox, agarwood moxibustion, TCM-inspired prenatal massages, and Indonesian traditional abdominal binding. In addition to these treatments, the company manufactures and distributes various products. Their product line features TCM-inspired supplements, including the Beauty Lab home herbal uterine care patch, probiotic intimate wash, and Yin nourishing pill sets. They also offer beauty products like a ginseng soothing anti-allergy moisturizing wash for various skin issues and solutions for scalp health. The company further provides consultancy services, offering technical training in TCM-inspired therapies and dietary guidance to other well-regarded beauty salons, massage centers, and similar institutions. These services and products are specifically formulated to alleviate premenstrual syndrome, menstrual irregularities, dysmenorrhea, leukorrhea, pelvic inflammatory disease, menopausal symptoms, and concerns related to breast and uterine health. They also contribute to enhancing overall physical strength and balancing endocrine functions, addressing a wide array of common women's health challenges. Charming Medical operates its own network of wellness centers. Founded in 2016, the company maintains its headquarters in Causeway Bay, Hong Kong.

Charming Medical Limited Class A Ordinary Shares is led by CEO Kit Wong, employs 49 people, headquartered in HK, publicly traded since 2025.

Charming Medical Limited Class A Ordinary Shares (MCTA) stock trades at $29.36 with a market capitalization of $445.55M. The stock is valued at a price-to-earnings (P/E) ratio of 414.62, price-to-book of 10097.17, price-to-sales of 71.61. Over the past 52 weeks the stock has ranged between $4.30 and $31.70, and currently trades 7.4% below its 52-week high.

On profitability, Charming Medical Limited Class A Ordinary Shares generates a return on equity (ROE) of -232.79%, return on capital employed of 341.03%, an operating margin of 22.32%, a net profit margin of 19.27%.

Official website: charmingmed.com